Search research articles
Contact Us
Filters
Showing results (51-60 of 213) with videos related to
Page
of 22
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2025
Cancer-control outcomes of Radium- 223-pretreated lutetium- 177-PSMA Radioligand vs. Radium- 223-naïve mCRPC patients
Mike Wenzel, Lena Theissen, Daniel Groener, et al.
Urologic Oncology
|
October 16, 2022
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany
Mike Wenzel, Angelika Borkowetz, Verena Lieb, et al.
World Journal of Urology
|
November 2, 2024
Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer
Mike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Theranostics
|
March 14, 2025
Cancer-control outcomes with [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy in elderly, frail or comorbid mCRPC patients
Mike Wenzel, Carolin Siech, Cristina Cano Garcia, et al.
Urologic Oncology
|
July 28, 2024
Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: Differences in biochemical recurrence-free survival after radical prostatectomy
Carolin Siech, Benedikt Hoeh, Eike Rohlfsen, et al.
The Prostate
|
May 30, 2024
Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real-world setting of metastatic hormone-sensitive prostate cancer patients
Mike Wenzel, Benedikt Hoeh, Fabienne Hurst, et al.
Urologic Oncology
|
July 31, 2021
The effect of race on stage at presentation and survival in upper tract urothelial carcinoma
Claudia Collà Ruvolo, Mike Wenzel, Luigi Nocera, et al.
European Urology Focus
|
December 6, 2024
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE Data
Benedikt Hoeh, Mike Wenzel, Zhe Tian, et al.
The Prostate
|
July 19, 2023
Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy
Mike Wenzel, Cristina C Garcia, Benedikt Hoeh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 4, 2021
Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study
Claudia Collà Ruvolo, Christoph Würnschimmel, Luigi Nocera, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 213) with videos related to
Sort By:
Page
of 22
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2025
Cancer-control outcomes of Radium- 223-pretreated lutetium- 177-PSMA Radioligand vs. Radium- 223-naïve mCRPC patients
Mike Wenzel, Lena Theissen, Daniel Groener, et al.
Urologic Oncology
|
October 16, 2022
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany
Mike Wenzel, Angelika Borkowetz, Verena Lieb, et al.
World Journal of Urology
|
November 2, 2024
Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer
Mike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Theranostics
|
March 14, 2025
Cancer-control outcomes with [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy in elderly, frail or comorbid mCRPC patients
Mike Wenzel, Carolin Siech, Cristina Cano Garcia, et al.
Urologic Oncology
|
July 28, 2024
Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: Differences in biochemical recurrence-free survival after radical prostatectomy
Carolin Siech, Benedikt Hoeh, Eike Rohlfsen, et al.
The Prostate
|
May 30, 2024
Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real-world setting of metastatic hormone-sensitive prostate cancer patients
Mike Wenzel, Benedikt Hoeh, Fabienne Hurst, et al.
Urologic Oncology
|
July 31, 2021
The effect of race on stage at presentation and survival in upper tract urothelial carcinoma
Claudia Collà Ruvolo, Mike Wenzel, Luigi Nocera, et al.
European Urology Focus
|
December 6, 2024
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE Data
Benedikt Hoeh, Mike Wenzel, Zhe Tian, et al.
The Prostate
|
July 19, 2023
Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy
Mike Wenzel, Cristina C Garcia, Benedikt Hoeh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 4, 2021
Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study
Claudia Collà Ruvolo, Christoph Würnschimmel, Luigi Nocera, et al.
Page
of 22